107 related articles for article (PubMed ID: 6949238)
1. Prevention of blastic crisis in Ph1-positive chronic myeloid leukemia.
Sharp JC
Recent Results Cancer Res; 1982; 80():78-82. PubMed ID: 6949238
[TBL] [Abstract][Full Text] [Related]
2. Chronic granulocytic leukemia: cytogenetic conversion of the bone marrow with cycle-specific chemotherapy.
Smalley RV; Vogel J; Huguley CM; Miller D
Blood; 1977 Jul; 50(1):107-13. PubMed ID: 266951
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia].
Papa G; Amadori S; Monarca B; Alimena G; Esposito A; Mandelli F
Haematologica; 1972; 58(9):597-600. PubMed ID: 4206235
[No Abstract] [Full Text] [Related]
4. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
[TBL] [Abstract][Full Text] [Related]
5. [Chromosome analysis and TdT determination: important prognostic parameters of blastic crises in chronic myelocytic leukemia].
Schwarzmeier JD; Haas O; Paietta E; Fischer P
Wien Klin Wochenschr; 1982 Oct; 94(19):514-20. PubMed ID: 6760560
[TBL] [Abstract][Full Text] [Related]
6. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
Sadamori N; Sandberg AA
Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
[TBL] [Abstract][Full Text] [Related]
7. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani PL; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy.
Canellos GP; DeVita VT; Whang-Peng J; Chabner BA; Schein PS; Young RC
Blood; 1976 Jun; 47(6):1003-9. PubMed ID: 1064434
[TBL] [Abstract][Full Text] [Related]
9. Blast crisis of chronic myeloid leukaemia: the effect of intensive chemotherapy.
Beard M; Gauci C; Sikora E; Kirk B; Fairley GH; Wrigley P
Scand J Haematol; 1976 Apr; 16(4):258-62. PubMed ID: 1064906
[TBL] [Abstract][Full Text] [Related]
10. Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis.
Thomas MR; Robinson WA; Dantas M; Koeppler H; Drebing C; Glode LM
Am J Hematol; 1984 Feb; 16(2):105-12. PubMed ID: 6364801
[TBL] [Abstract][Full Text] [Related]
11. Effect of early splenectomy and cyclic acute leukemia-like chemotherapy on the course of chronic myeloid leukemia.
Baccarani M; Guolo ML; Tura S
Boll Ist Sieroter Milan; 1978 Jul; 57(3):360-9. PubMed ID: 282906
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of adult acute nonlymphoblastic leukemia.
Levi JA; Vincent PC; Gunz FW
Ann Intern Med; 1972 Mar; 76(3):397-403. PubMed ID: 4502024
[No Abstract] [Full Text] [Related]
13. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
Resegotti L; Falda M; Rossi M; Infelise VE
Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
[No Abstract] [Full Text] [Related]
14. Karyotypic conversion in Ph1-positive chronic myeloid leukaemia with combination chemotherapy.
Sharp JC; Joyner MV; Wayne AW; Kemp J; Crofts M; Birch AD; McArthur G; Lai S; Sterndale H; Williams Y
Lancet; 1979 Jun; 1(8131):1370-2. PubMed ID: 87832
[TBL] [Abstract][Full Text] [Related]
15. Combinations of arabinosyl cytosine and 6-thioguanine for treatment of adults with acute leukemia.
Bodey GP; Freireich EJ; McCredie KB; Rodriguez V; Burgess MA; Frei E
Med Pediatr Oncol; 1975; 1(1):29-35. PubMed ID: 1066520
[TBL] [Abstract][Full Text] [Related]
16. Terminal-phase chronic myelogenous leukemia: approaches to treatment.
Allen SL; Coleman M
Cancer Invest; 1985; 3(5):491-503. PubMed ID: 3902166
[TBL] [Abstract][Full Text] [Related]
17. Optimism in leukemia treatment.
Can Med Assoc J; 1973 Apr; 108(7):821. PubMed ID: 4513359
[No Abstract] [Full Text] [Related]
18. Involvement of chromosomes 8, 9, 19 and 22 in PH1 positive and PH1 negative chronic myelocytic leukemia in the chronic or blastic stage.
Gahrton G; Lindsten J; Zech L
Acta Med Scand; 1974 Nov; 196(5):355-60. PubMed ID: 4531216
[No Abstract] [Full Text] [Related]
19. Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
Lönnqvist B; Andersson B; Björkholm M; Engstedt L; Gahrton G; Hast R; Holm G; Killander A; Lantz B; Lockner D; Mellstedt H; Palmblad J; Paul C; Peterson C; Simonsson B; Stalfelt AM; Udén AM; Wadman B; Oberg G
Cancer Chemother Pharmacol; 1982; 9(2):89-92. PubMed ID: 7172410
[TBL] [Abstract][Full Text] [Related]
20. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
